Navigation Links
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Date:7/1/2009

eered human insulin, the first therapeutic derived from gene cloning. In 1987, Ullrich and collaborators discovered that the neu/HER2 gene is amplified and overexpressed in more than 30 percent of invasive breast cancers. HER2 was chosen for the development of an entirely novel cancer therapy, culminating in the production of an anti-HER2 monoclonal antibody that since 1998 has been used successfully to treat patients with metastatic breast cancer. This was the first targeted therapeutic agent developed on the basis of a newly discovered gene with an oncogenic function in human cancer.

In the early 1990s, Ullrich identified the signaling system involved in regulating tumor angiogenesis, the growth of blood vessels in tumors. He discovered that inhibiting a key player in the signaling system (called vascular endothelial growth factor receptor or VEGFR) suppresses the generation of blood vessels in tumors and slows down cancer cell growth. Years later, a small molecule inhibitor of the VEGFR2 kinase function was developed, from which a derivative was approved in 2006 for the treatment of kidney carcinoma and gastro-intestinal stromal tumors.

"It is an honor to receive an award of this stature and to be recognized among so many outstanding scientists," said Ullrich. "Dr. Paul is a legend whose work had a tremendous impact on combating some of the world's most serious diseases. Four of the more than 80 medicines he developed are on the World Health Organization's list of essential medicines."

"Johnson & Johnson is pleased the Selection Committee chose Dr. Ullrich as the recipient of the 2009 Dr. Paul Janssen Award, as we believe that his discoveries capture the spirit and legacy of Dr. Paul," said Paul Stoffels, M.D., global head, Research & Development, Pharmaceuticals, Johnson & Johnson. "Dr. Paul's passion for his work and dedication to creating life-saving therapies for the individuals most in need shou
'/>"/>

SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
4. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
5. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Video: Keppra XR(TM) Approved in the U.S.
10. Video: Fortune 1000 Executives: New President Must Fix Education Gap
11. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Best in the Nation ,, PHILADELPHIA, Dec. ... it has been granted Magnet(R) recognition by the ... Magnet(R) is one of the highest levels of ... and places Hahnemann among the five percent of ... prestigious distinction. ,, At 9:00 am on Monday, ...
(Date:12/16/2009)... Decision Resources, one of the world,s leading research ... finds that, according to responses from surveyed dermatologists, ... interleukin inhibitors) will capture 22 percent of the ... for moderate to severe psoriasis. Among these two ... three times as much patient share as briakinumab. ...
(Date:12/16/2009)... the ultimate CHO cell culture supplement? InVitria has what scientists ... culture media supplement that improves the growth and productivity of ... performance, Zap-CHO is an animal free, well defined and consistent ... ... Collins, CO (PRWEB) December 16, 2009 -- Scientists working with ...
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader ... international validation of the cutting-edge science behind its ... around the world rediscovered the Cyclin G1 ... cancer pathogenesis and disease progression, and thus a ... the NIH National Cancer Institute investigating the role ...
Breaking Biology Technology:Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... Metavante Corp , the financial technology subsidiary of ... in June, of Herndon, Va.-based TREEV, LLC, ... the financial industry. The company delivers browser-based document and ... TREEV will become a subsidiary of Advanced Financial Solutions ...
... in UW-Madison's RFID Lab is so strong that a ... all of the 120 spots available for the tour were taken. ... canceling" to make room for those on the list, said Nancy ... shows that people are really excited about RFID." , ,Visitors will ...
... Waukesha, Wis . -- GE Healthcare will ... Repair, using GE Healthcare's cellular imaging system, the IN ... nervous system and neurodegenerative diseases like Parkinson's and Alzheimer's ... the Harvard center and GE will work together to ...
Other Biology Technology:
(Date:12/16/2009)... National Instruments (Nasdaq: NATI ... control, and DENSO Robotics, a leader and ... today announced their collaboration to integrate NI ... arms. The collaboration increases productivity and performance ... applications. In today,s trend toward high-mix, low-volume ...
(Date:12/16/2009)... European Union (EU) member states ... which are increasingly subjected to unauthorised immigration ... advanced technology security and IT-based systems will ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, New analysis from ... Border Security Market Assessment - European Union ...
(Date:12/15/2009)... such as Alzheimer,s and Parkinson,s, doctors can reach into ... patient. , But they come up empty-handed when they ... ataxia disabling disorders that rob people of their ... trying to change that with the help of a ... Neurological Disorders and Stroke to establish a nationwide network ...
Breaking Biology News(10 mins):National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 2Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 3UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Give Life for the Fourth of July 49555 1Give Life for the Fourth of July 49555 2Give Life for the Fourth of July 49555 3Researchers uncover approach for possibly eradicating HIV infection 49554 1Researchers uncover approach for possibly eradicating HIV infection 49554 2The battle for CRTC2 3A How obesity increases the risk for diabetes 8937 1The battle for CRTC2 3A How obesity increases the risk for diabetes 8937 2The battle for CRTC2 3A How obesity increases the risk for diabetes 8937 3
... possible to solve climate change, reduce poverty and save biodiversity ... but this is exactly the issue that is being discussed ... 3-14 December 2007. The key is to include reduced emissions ... that developing countries can be compensated for saving their forests ...
... in eastern Australia now have greater access to the ... NSW Department of Primary Industries (DPI). , Trials undertaken ... cold storage at temperatures of 2 or 3C can ... 14 to16 days. , Cold treatment at these temperatures ...
... release is available in Spanish . , How ... Peninsula live six million years ago" The researcher of the ... answer this question through his doctoral thesis "Rodents and insectivorous ... of the Guadix basin", supervised by doctors Elvira Martn and ...
Other Biology News:Having the climate cake and eating it, too 2Cold treatment opens doors for citrus exports to Japan 2Rodent fossils allows to determine climate of the Iberian Peninsula 6 million years ago 2
... stimulating factors for assays of mouse hematopoietic ... fetal liver. Suitable for the growth ... when added to methylcellulose at a final ... Will also support growth of mouse ...
Mouse monoclonal antibody to FMN2 - formin 2...
...
Anti-Human Complement Component C4c, IgY fraction (Polyclonal) (chicken IgY)...
Biology Products: